BioSpace News Archive

Gravity Diagnostics is a CLIA certified, and CAP-accredited laboratory licensed in all 50 states that processed nearly 50% of the Commonwealth of Kentucky COVID-19 gold standard PCR tests during the pandemic.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that scientists from the Regeneron Genetics Center® (RGC) have discovered rare genetic mutations in the GPR75 gene associated with protection against obesity.

PharmaForce International recently published a benchmarking report that profiles over forty of the leading Oncology Sales and Marketing organizations in the United States.

The Global Patient Handling Equipment market accounted for USD 15.8 Billion in 2020 and is expected to reach USD 25.9 Billion by 2028, growing at a CAGR of around 6.1% between 2021 and 2028.

A new study entitled “n-6 High Fat Diet Induces Gut Microbiome Dysbiosis and Colonic Inflammation” was released to the public this week, co-authored by Dr. Sabine Hazan, creator of ProgenaBiome, a genetic sequencing research laboratory.

tab32, the dental industry’s #1 cloud-based, full-service technology platform, today announced the appointment of three top industry experts to its advisory board.

Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, celebrates that ten years ago, the company introduced the Equinoxe® shoulder system’s augmented reverse baseplate and armed surgeons with a new solution for treating patients who suffer from severe glenoid deformity.

Universal data connectivity for life science laboratories delivers seamless digital ecosystem and full automation of lab workflows – with the goal of accelerating scientific discovery

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the appointment of Pablo Urbaneja as Senior Vice President, Corporate Development.

BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), today announced the appointment of Dave Jenkins as Chief Financial Officer.